Johnson & Johnson Reportedly Settles California Talc Case Midtrial

Johnson & Johnson JNJ has settled its California talc case midtrial and is likely to avoid a huge judgement, according to Law 360.

Alameda County Superior Court Judge Stephen Kaus in Oakland, California reportedly made the announcement to the jury today.

Johnson & Johnson has faced more than 14,000 claims that its talc powder caused ovarian cancer and mesothelioma, a rare cancer linked to asbestos exposure.

In December, a jury in Los Angeles sided with the company in the case of Amy Fong, who alleged Johnson & Johnson’s talc contained asbestos and caused her to develop mesothelioma, reports the Fierce Pharma.

Johnson & Johnson shares were down 0.49% at $143.59 at the time of publication. The stock has a 52-week high of $148.99 and a 52-week low of $121.

Related Links:

Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder

Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements

Public domain photo via Wikimedia

Market News and Data brought to you by Benzinga APIs
Posted In: NewsLegalMediaLaw 360
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...